A total of 722 patients (374 men and 348 women, aged from three months to 57 years) were treated with topiramate during the period 2002–2012. Epilepsy was diagnosed and antiepileptic treatment was evaluated using follow-up video-EEG monitoring. Topiramate was effective in 465 patients (64.4%), the efficacy of monotherapy (72.2%) being greater than that of combined therapy (61.9%). Low efficacy was noted in 198 patients (27.4%). Aggravation was seen in 59 cases (8.2%). Compliance (remaining on treatment for more than one year) was 60.79%. High efficacy in children aged less than one year was seen in 55.2% of cases, while low efficacy was seen in 34.5% and aggravation in 10.3%; among children aged 1–3 years, high efficacy was seen in 54.8% and low efficacy was seen in 31.8%, with aggravation in 13.4%; in children aged over three years, efficacy was high in 67.3% and low in 26.2%, with aggravation in 6.5%; in the adult population aged over 18 years, the agent was effective in 82.1% of patients, with low efficacy in 16.6%, and aggravation in just one patient. Topiramate demonstrated high efficacy in the treatment of idiopathic generalized forms of epilepsy (IGE) without absences, as well as in symptomatic/cryptogenic focal forms of epilepsy. Increases in patients’ age were associated with increases in the efficacy of topiramate, while the risk of aggravation decreased significantly.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. A. Balakireva, A. F. Neretina, and O. V. Ivashchenko, “Experience in the use of Topamax in the treatment of epilepsy in young children,” Russ. Zh. Detsk. Nevrol., III, No. 4, 3–7 (2008).
A. B. Gekht, L. E. Mil’chakova, and E. I. Gusev, “Experience in the use of Topamax: clinical and pharmacoeconomic aspects,” Zh. Nevrol.Psikhiat., 107, No. 12, 40–44 (2007).
L. Yu. Glukhova, K. Yu. Mukhin, and A. S. Petrukhin, “Use of topiramate in the combined therapy of malignant epileptic encephalopathies with debut in the neonatal period,” Russ. Zh. Detsk. Nevrol., I, No. 2, 10–14 (2006).
M. Yu. Dorofeeva, A. Yu. Ermakov, and E. D. Belousova, “Efficacy of topiramate (Topamax) in the treatment of resistant epilepsy in children,” Zh. Nevrol. Psikhiat., 105, No. 11, 21–23 (2005).
K. Yu. Mukhin, L. Yu. Glukhova, A. S. Petrukhin, et al., “Topamax in the monotherapy of epilepsy,” Zh. Nevrol. Psikhiat., 104, No. 8, 35–40 (2004).
K. Yu. Mukhin, M. D. Tysyachina, L. N. Mukhina, and A. S. Petrukhin, “Comparative efficacy and tolerance of topiramate, valproates, and carbamazepine in the monotherapy of epilepsy in children and young adults,” Russ. Zh. Detsk. Nevrol., III, No. 2, 3–48 (2008).
S. N. Sivkova, V. F. Prusakov, and F. M. Zaikova, “Topiramate in the treatment of epilepsy in young children,” Russ. Zh. Detsk. Nevrol., III, No. 4, 7–16 (2008).
T. A. Glauser, D. J. Dlugos, W. E. Dodson, et al., and EPMN-106/INT-28 Investigators, “Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents,” J. Child Neurol., 22, No. 6, 693–699 (2007).
R. Guerrini, J. Carpay, J. van Oene, et al., and TOP-INT-51 Investigators Group, “Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting,” Seizure, 14, No. 6, 371–380 (2005).
A. Labate, A. Siniscalchi, L. Mumoli, et al., “Topiramate and temporal lobe epilepsy: an open-label study,” Epileptic Disord., 14, No. 2, 163–166 (2012).
V. Puri, S. Ness, S. J. Sattaluri, et al., “Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures,” J. Child Neurol., 26, No. 10, 1271–1283 (2011).
I. Valencia, C. Fons, S. V. Kothare, et al., “Efficacy and tolerability of topiramate in children younger than 2 years old,” J. Child Neurol., 20, No. 8, 667–669 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 113, No. 4, Iss. II, Epilepsy, pp. 45–51, April, 2013.
Rights and permissions
About this article
Cite this article
Kholin, A.A., Zavadenko, N.N., Il’ina, E.S. et al. Relationship between the Efficacy and Safety of Topiramate and Patients’ Ages and Types of Epilepsy. Neurosci Behav Physi 44, 765–771 (2014). https://doi.org/10.1007/s11055-014-9981-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-014-9981-7